Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia

Jennifer M. Dan, Susan M. Lehman, Rita Al-Kolla, Samuel Penziner, Kamyar Afshar, Gordon Yung, Eugene Golts, Nancy Law, Cathy Logan, Zsuzsanna Kovách,

The Journal of Infectious Diseases · 2022 · 34 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Bacteriophage therapy is the use of viruses to kill bacteria for the treatment of antibiotic-resistant infections. Little is known about the human immune response following phage therapy. We report the development of phage-specific CD4 T cells alongside rising phage-specific immunoglobulin G and neutralizing antibodies in response to adjunctive bacteriophage therapy used to treat a multidrug-resistant Pseudomonas aeruginosa pneumonia in a lung transplant recipient. Clinically, treatment was considered a success despite the development phage-specific immune responses.

References

13